The world’s largest sportswear company will spend two days next week telling investors why it deserves their patience. Nike will host its Investor Day on November 16 and 17, 2026, its first since 2017, and expectations are low enough that any credible plan could move the stock. That is not a compliment. It is an indictment of where the business finds itself.
Nike stock is still down 32% over the past year, the worst showing of any stock in the Dow in 2026. The decline is not a valuation quirk. The business has been shrinking. More telling is what happened to profitability. Nike’s EBIT margin ran between roughly 12.7% and 16.2% from fiscal 2021 to fiscal 2024, then fell to about 8.2% in fiscal 2025. Nike reported an EBIT margin of 8.3% in fiscal 2026. Analysts currently model just 5.7% for the current fiscal year.
Who Filled the Gap
While Nike reorganised its channel strategy and cleared excess inventory, two focused competitors built loyal communities among exactly the customers Nike needs most. HOKA, owned by Deckers Outdoor Corporation, grew fiscal 2026 sales 15.9% to about $2.59 billion. On grew 2025 sales 30% to CHF 3.01 billion, capturing share from legacy players including Nike through premium pricing rather than discounting.
The strategic irony is real. Nike ceded the technically-obsessed running customer precisely when that customer became the most valuable one to own. A runner who buys on performance recommendations and wears the same shoe in race and commute is a high-margin, loyal, word-of-mouth machine. Hoka and On built their businesses on exactly that person.
What the Reset Has Built
There is genuine evidence the product pivot is working. Nike has now delivered five consecutive quarters of double-digit growth in NIKE Running, and management has said that over that period it added roughly $1 billion to the running business and gained five points of running market share in statement footwear across Western Europe and North America. CEO Elliott Hill restructured the company around sport verticals, shifting roughly 8,000 employees into vertical sport teams to connect athlete insights more closely with product development, marketing, and operations.
The innovation pipeline has real products in it, not vague promises. Hill has highlighted Nike Mind and AeroFit, and described continued Nike Air work, but the specific product name and framing around an upcoming ACG outdoor-running platform called Radical Air is not something Nike has publicly confirmed.
The Number That Matters
Investor Day is not really about the product slides. It is about one line on a financial framework. The Pace cost program targets about $2.5 billion in savings through fiscal 2031, and on November 17, management will lay out a five-year financial framework. Stifel expects that framework to outline a low-single-digit revenue growth rate and a low-double-digit EBIT margin, supporting projected earnings of $3 per share by fiscal 2031.
The timing of when most of Pace’s benefits arrive has not been laid out as specifically as fiscal 2029 and 2030, so margin sustainability will depend on disciplined execution in the interim. The stock trades at roughly 32 times this year’s earnings expectations, so investors are already paying for a recovery, not a slump. That valuation leaves almost no room for a vague answer.
A disciplined long-term investor would study this closely. The brand still commands unmatched scale, athlete relationships, and global retail infrastructure. Product innovation remains one of the most important catalysts for Nike’s recovery, and the investor day should provide significantly greater visibility into the company’s innovation pipeline. The question Tuesday is whether Hill can prove that Nike’s advantages are compounding again, rather than simply stabilising. If the margin plan clears the bar, the runway to fiscal 2030 is long and the starting point is genuinely depressed. If it does not, patience alone is not an investment thesis.
